Foresters Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-56,900
Closed -$4.99M 311
2019
Q2
$4.99M Sell
56,900
-8,600
-13% -$734K 0.09% 274
2019
Q1
$5.93M Buy
65,500
+2,000
+3% +$170K 0.1% 262
2018
Q4
$4.56M Buy
63,500
+11,500
+22% +$927K 0.09% 271
2018
Q3
$4.99M Buy
+52,000
New +$5.04M 0.08% 302

Other funds holding XBI

Foresters Investment Management's XBI Position: Q3 2019 in Review

Foresters Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 56,900 shares — an estimated $4.99M sold.

Foresters Investment Management first reported a position in XBI in Q3 2018 and held it in 4 quarters. The position peaked at $5.93M in Q1 2019. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.

  • Foresters Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
  • Foresters Investment Management sold 56,900 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $4.99M.
  • Foresters Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 4 quarters.
  • Foresters Investment Management's State Street SPDR S&P Biotech ETF position peaked at $5.93M in Q1 2019.
  • 406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.